Liquid Biopsies to identify ctDNA in blood & relevance to ILC (Invasive Lobular Cancer) & other BCs
Further to the discussion on British Researchers on early detection of BC using Blood Tests ...... A promising Blood Test Breakthrough in the UK identifying best treatment. | BCNA Online Network This first recording (first session of a four part series) on liquid biopsy/CtDNA tests and relevance for ILC on the Lobular Breast Cancer Website will be of interest to those who are diagnosed with Invasive Lobular Cancer. Dr Foldi also describes the describes the difference in shape of ILC vs other BCs ... and how some scans will miss it - but others will pick it up. Put the video on FULL SCREEN, for the best viewing option. https://lobularbreastcancer.org/liquid-biopsy-webinar-series-view-session-1-on-demand/ If you have a diagnosis of ILC and haven't 'subscribed' to the Lobular Breast Cancer Website yet (for their emails & updates) I would recommend that you do, as they are keeping up to date with all things ILC & regularly send out emails, advising you of these advancements too. https://lobularbreastcancer.org/ Keep your eyes open for the next 3 sessions - if you've subscribed you should be advised when they come up! If I see the updates, I'll add them here, so they are all together. Remember that KNOWLEDGE IS POWER ... the more you understand about your diagnosis of ILC, you'll feel more confident discussing treatments and/or concerns you may have during treatment & after treatment has been completed. Take care, stay wellA promising Blood Test Breakthrough in the UK identifying best treatment.
There are already a few tests out there predicting which type of treatment will be best for your type of Breast Cancer, but they can cost thousands of dollars - hopefully this one isn't as expensive, if and when it becomes available to patients. A new, simple blood test can predict which breast cancer treatment will work best, study finds DNA test means patients could be offered most effective treatment first, boosting their chances of beating the disease. The test, developed by a team at the Institute of Cancer Research, London (ICR), analyses circulating tumour DNA (ctDNA), which is released into the blood of patients by cancer cells. (my edit: there has been huge interest in Circulating Tumour Cells (ctDNA) for well over 5 years now, as these are the microscopic cancer cells that may be missed with surgery & chemo/treatment - possibly leading to recurrence further down the line.) https://www.theguardian.com/science/2026/jan/18/simple-blood-test-can-predict-which-breast-cancer-treatment-will-work-best-study-finds I've added the pdf of the article in case you can't access the Website